BG
CASC

BlackRock Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History

BlackRock Group’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,650
Closed -$172K – 3094
2015
Q2 		$172K Hold
7,650
– – ﹤0.01% 2606
2015
Q1 		$75K Buy
+7,650
New +$75K ﹤0.01% 2701
2014
Q2 		– Sell
-21,656
Closed -$389K – 2871
2014
Q1 		$389K Buy
+21,656
New +$389K ﹤0.01% 2287